Non-small Cell Lung Cancers (NSCLC)
A case study showing how the Ergomed team successfully provided full services for the first non-interventional epidemiology study in NSCLC conducted in different countries in the MENA region. This study resulted in, for the first time ever, generation of important data on the prevalence of ALK rearrangement in the Middle East and North Africa.
- 6 study sites across 5 countries: Egypt, Saudi Arabia, United Arab Emirates, Lebanon and Morocco
- 448 samples retrospectively collected from study center tissue banks, were analyzed for anaplastic lymphoma kinase (ALK) gene rearrangement using the Ventana ALK-IHC method at each of the centers
- The primary aim of this retrospective study was to estimate the prevalence of ALK rearrangement in the MENA population using NSCLC clinical samples, as the existing epidemiological data is very limited
Read further to learn more about Ergomed’s oncology and Real-World Evidence expertise: Non-small Cell Lung Cancers (NSCLC)-Case-Study